Richard Marcus, MD
Cardiovascular Disease · West Des Moines, IANPI 1023090057
Payments from drug & device makers
What this record shows
6 manufacturers reported payments, led by Medical Device Business Services, Inc. at 40.9% of the total. Reporting peaked in 2022 at $644 and has fallen 95.9% since, to $26 in 2025. That places this record below the midpoint for cardiovascular disease clinicians in IA, where the typical reported total is $1,334.
Across 8 payments — averaging $111.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$366
- Biosense Webster, Inc.$278
- Siemens Medical Solutions USA, Inc.$134
- Philips North America LLC$67
- Abbott$26
- Alnylam Pharmaceuticals Inc.$23
Across 1 payment — averaging $3696.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Siemens Medical Solutions USA, Inc.$4K
What the payments were for
- Travel & lodging$36641%
- Food & beverage$52859%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 1 | $366 |
| Biosense Webster, Inc. | 2 | $278 |
| Siemens Medical Solutions USA, Inc. | 2 | $134 |
| Philips North America LLC | 1 | $67 |
| Abbott | 1 | $26 |
| Alnylam Pharmaceuticals Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$515
- NUVISION ICE CATHETER$129
How this compares
$894 in reported general payments places this provider in the 40th percentile of 142 cardiovascular disease providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 46 | $55,006 |
| XareltoRivaroxaban | 20 | $31,370 |
| JardianceEmpagliflozin | 23 | $13,395 |
| Bumetanide | 71 | $2,584 |
| Metoprolol Succinate | 219 | $2,562 |
| Potassium Chloride | 29 | $879 |
| Bisoprolol Fumarate | 15 | $680 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 16 | $492 |
| Amlodipine Besylate | 92 | $381 |
| Metoprolol Tartrate | 72 | $358 |
| Spironolactone | 69 | $350 |
| Atorvastatin Calcium | 113 | $314 |
| Furosemide | 75 | $287 |
| SotalolSotalol Hcl | 14 | $282 |
| Lisinopril | 44 | $254 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in West Des Moines
- Troy HounshellWest Des Moines$164K
- Enrico MartinWest Des Moines$113K
- Suzanne FeigofskyWest Des Moines$59K
- Robert PaulWest Des Moines$9K
- Lucas GrobenWest Des Moines$6K
- Krishna Theja ReddyWest Des Moines$5K
- Randolph RoughWest Des Moines$3K
- Paul WesleyWest Des Moines$2K
- Brian OlshanskyIowa City$219K
- Gursukhman Deep SidhuDavenport$60K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.